Prot# C.2004.140: A Multi-Centered, Prospective, Randomized, Placebo-Controlled Clinical Trial for The Treatment of Significant Steatosis or NASH with Xenical Followed by Treatment of Hepatitis C (HCV) with PEG-Interferon alpha-2a/Copegus